ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Toni Pashley joins Scene Health as Chief Product Officer to help solve the Medication Adherence challenge

BALTIMORE, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Scene Health, a leader in MedEngagement, welcomes Toni Pashley as its new Chief Product Officer (CPO), marking a transformative moment for Scene as they accelerate their technological innovations to support true medication adherence: helping people take their medication as prescribed, every day. Medication non-adherence remains at epidemic levels, costing the US healthcare system more than $500B per year in preventable hospitalizations.

With a proven track record of developing large-scale integrated platforms in digital health, Pashley is set to elevate Scene Health’s product to a new level of interoperability, scalability, and innovation. In this newly created role, Pashley will leverage her leadership experience to drive the product vision and market positioning for Scene Health, making Scene a change maker in virtual care with demonstrable and independently validated ROI. Pashley’s experience in data analytics, engagement, and behavior change programs will add an increased focus on the patient experience and data insights offered by Scene Health.

“I’m excited to join Scene Health and use my health technology experience to solve complex challenges for clinical engagement across health plans, providers, and patients,” says Pashley. “I look forward to collaborating with the talented team at Scene Health to further the mission of driving real, tangible impact on people's health and the costs of healthcare. The distinctive video engagement capabilities offered by Scene present a compelling and novel opportunity while addressing a pressing need in healthcare.”

Pashley joins Scene Health from Sharecare, where she was the EVP & Chief Product Officer, helping grow the business and leading both product and engineering teams from startup to a publicly traded company. Her prior work across organizations like CNN, the CDC, NCR, and AT&T has equipped her with a unique understanding of the complexities of data integration and software development.

“Toni Pashley is a proven healthcare executive and leader, and we are very excited to have her on board. Her vision and commitment to rapid technological advancement make her the ideal leader for our team as we scale,” said Sebastian Seiguer, CEO of Scene Health. “When people with chronic conditions take their medication as prescribed, they get sick less often and stay out of the hospital. Toni will be instrumental in making our market-leading video Directly Observed Therapy (video DOT) solution available to more and more people who need support in taking medication as prescribed.” Scene’s video DOT is the gold standard for medication adherence and has been integrated into CDC treatment guidelines. More than twenty-five peer-reviewed publications and customer studies demonstrate Scene’s ability to help improve condition control and prevent hospitalization.

About Scene Health
Scene Health's 360° model of care utilizes Directly Observed Therapy through video technology to address the $500B medication non-adherence problem. Scene currently delivers programs for government-sponsored health plans, public health departments, and life science organizations covering multiple chronic and infectious conditions, including diabetes, hypertension, asthma, CHF, cholesterol control, opioid use disorder, hepatitis C, tuberculosis, and solid organ transplant. For further information, please contact info@scene.health.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8e510af3-00e2-4a71-8416-f234ca638105


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.